Carbone DP - Search Results

1

Proteomic patterns of tumour subsets in non-small-cell lung cancer.

Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, Roberts JR, Edgerton M, Gonzalez A, Nadaf S, Moore JH, Caprioli RM, Carbone DP. Yanagisawa K, et al. Among authors: carbone dp. Lancet. 2003 Aug 9;362(9382):433-9. doi: 10.1016/S0140-6736(03)14068-8. Lancet. 2003. PMID: 12927430

2

A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer.

Chen HL, Gabrilovich D, Tampé R, Girgis KR, Nadaf S, Carbone DP. Chen HL, et al. Among authors: carbone dp. Nat Genet. 1996 Jun;13(2):210-3. doi: 10.1038/ng0696-210. Nat Genet. 1996. PMID: 8640228

3

Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.

Gabrilovich DI, Nadaf S, Corak J, Berzofsky JA, Carbone DP. Gabrilovich DI, et al. Among authors: carbone dp. Cell Immunol. 1996 May 25;170(1):111-9. doi: 10.1006/cimm.1996.0140. Cell Immunol. 1996. PMID: 8665591

4

Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells.

Oyama T, Ran S, Ishida T, Nadaf S, Kerr L, Carbone DP, Gabrilovich DI. Oyama T, et al. Among authors: carbone dp. J Immunol. 1998 Feb 1;160(3):1224-32. J Immunol. 1998. PMID: 9570538

5

Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo.

Gabrilovich D, Ishida T, Oyama T, Ran S, Kravtsov V, Nadaf S, Carbone DP. Gabrilovich D, et al. Among authors: carbone dp. Blood. 1998 Dec 1;92(11):4150-66. Blood. 1998. PMID: 9834220 Free article.

6

Dendritic cells transduced with wild-type p53 gene elicit potent anti-tumour immune responses.

Ishida T, Chada S, Stipanov M, Nadaf S, Ciernik FI, Gabrilovich DI, Carbone DP. Ishida T, et al. Among authors: carbone dp. Clin Exp Immunol. 1999 Aug;117(2):244-51. doi: 10.1046/j.1365-2249.1999.00913.x. Clin Exp Immunol. 1999. PMID: 10444254 Free PMC article.

7

Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.

Gabrilovich DI, Ishida T, Nadaf S, Ohm JE, Carbone DP. Gabrilovich DI, et al. Among authors: carbone dp. Clin Cancer Res. 1999 Oct;5(10):2963-70. Clin Cancer Res. 1999. PMID: 10537366

8

Clinical significance of defective dendritic cell differentiation in cancer.

Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, Carbone DP, Gabrilovich DI. Almand B, et al. Among authors: carbone dp. Clin Cancer Res. 2000 May;6(5):1755-66. Clin Cancer Res. 2000. PMID: 10815894 Clinical Trial.

9

Chromosome 19 translocation, overexpression of Notch3, and human lung cancer.

Dang TP, Gazdar AF, Virmani AK, Sepetavec T, Hande KR, Minna JD, Roberts JR, Carbone DP. Dang TP, et al. Among authors: carbone dp. J Natl Cancer Inst. 2000 Aug 16;92(16):1355-7. doi: 10.1093/jnci/92.16.1355. J Natl Cancer Inst. 2000. PMID: 10944559 No abstract available.

10

Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.

Jagasia MH, Langer CJ, Johnson DH, Yunus F, Rodgers JS, Schlabach LL, Cohen AG, Shyr Y, Carbone DP, Devore RF. Jagasia MH, et al. Among authors: carbone dp. Clin Cancer Res. 2001 Jan;7(1):68-73. Clin Cancer Res. 2001. PMID: 11205920 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters